Page last updated: 2024-11-08

thiophanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

thiophanate-methyl : A member of the class of thioureas that is the dimethyl ester of (1,2-phenylenedicarbamothioyl)biscarbamic acid. A fungicide effective against a broad spectrum of diseases in fruit, vegetables, turf and other crops including eyespot, scab, powdery mildew and grey mould. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Thiophanate: Nematocide used in livestock; also has fungicidal properties. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

thiophanate : A member of the class of thioureas that is the diethyl ester of (1,2-phenylenedicarbamothioyl)biscarbamic acid. A fungicide effective against a broad spectrum of diseases in fruit, vegetables, turf and other crops including eyespot, scab, powdery mildew and grey mould. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3032791
CHEMBL ID487187
CHEBI ID35014
SCHEMBL ID41622
SCHEMBL ID22261863
MeSH IDM0021369
PubMed CID3032792
CHEMBL ID2103777
CHEBI ID82060
SCHEMBL ID20842
MeSH IDM0021369

Synonyms (256)

Synonym
smr000778087
BIDD:ER0424
AC-12584
MLS002207244
carbamic acid, [1,2-phenylenebis(iminocarbonothioyl)]bis-, dimethyl ester
AKOS005443059
BRD-K90168339-001-02-9
methylthiophanate
nf 44
thiophanate methyl
enovit methyl
bas 32500f
nsc-170811
nsc170811
allophanic acid,4'-o-phenylenebis[3-thio-, dimethyl ester
methyl topsin
fungo
pelt 14
cercobin methyl
methylthiofanate
nf-44
o-bis(3-methoxycarbonyl-2-thioureido)benzene
1,2-bis(methoxycarbonylthioureido)benzene
thiophanate m
topsin m
td 1771
cercobin m
carbamic acid,2-phenylenebis(iminocarbonothioyl)]bis-, dimethyl ester
topsin methyl
enovit m
topsin nf-44
dimethyl [1,2-phenylenebis(iminocarbonothioyl)]biscarbamate
neotopsin
dimethyl 4,4'-o-phenylene-bis[3-thioallophanate]
dimethyl 4,4'-o-phenylenebis(3-thioallophanate)
1,2-bis[3-(methoxycarbonyl)-2-thioureido]benzene
23564-05-8
pelt 44
bis[(3-methoxycarbonyl)-2-thioureido]benzene
methyl thiophamate
DIVK1C_006844
SPECTRUM_001761
BSPBIO_002622
SPECTRUM5_001330
thiophanate-methyl
NCGC00091407-01
1,2-di-(3-methoxycarbonyl-2-thioureido)benzene
mildothane
dimethyl ((1,2-phenylene)bis-(iminocarbonothioyl))bis(carbamate)
ccris 6101
topsin wp methyl
ditek
carbamic acid, (1,2-phenylenebis(iminocarbonothioyl))bis-, dimethyl ester
easout
rcra waste no. u409
nsc 170811
caswell no. 375a
rilon
topsin nf 44
trevin
ai3-27905
dimethyl ((1,2-phenylene)bis(iminocarbonothioyl))bis(carbamate)
allophanic acid, 4,4'-o-phenylenebis(3-thio-, dimethyl ester
thiophanate-methyl [ansi:bsi:iso]
sipcavit
pei 190
epa pesticide chemical code 102001
f 6385
cycosin
topsin-m
einecs 245-740-7
sipcaplant
thiopan
sipcasan
fungo 50
enovit super
methyl thiophanate
topsin turf and ornamentals
hsdb 6937
1,2-bis(3-(methoxycarbonyl)-2-thioureido)benzene
brn 0937942
caligran
pelt-44
tiofanate metile [italian]
metoben
carbamic acid, (1,2-phenylenebis(iminocarbonothioyl)bis-, dimethyl ester
dimethyl (benzene-1,2-diyldicarbamothioyl)biscarbamate
STK366090
NCGC00091407-03
NCGC00091407-04
NCGC00091407-02
KBIO3_002122
KBIO1_001788
KBIO2_007377
KBIO2_004809
KBIOSS_002242
KBIO2_002241
KBIOGR_000392
SPECTRUM2_000646
SPECTRUM3_001211
SPECPLUS_000748
SPBIO_000651
SPECTRUM4_000096
SPECTRUM1503974
thiophanate, methyl ester
NCGC00091407-06
NCGC00091407-05
CHEMBL487187
chebi:35014 ,
methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate
NCGC00091407-08
NCGC00091407-07
cas-23564-05-8
dtxcid104338
tox21_300830
NCGC00259228-01
NCGC00254734-01
tox21_201679
dtxsid1024338 ,
n-[[2-[[(methoxycarbonylamino)-sulfanylidenemethyl]amino]anilino]-sulfanylidenemethyl]carbamic acid methyl ester
A816770
CCG-39648
tiofanate metile
unii-k4n81r84l8
k4n81r84l8 ,
enovit-methyl
FT-0630502
frumidor
carbamic acid, n,n'-(1,2-phenylenebis(iminocarbonothioyl))bis-, c,c'-dimethyl ester
thiophanate-methyl [hsdb]
dimethyl (1,2-phenylenebis(iminocarbonothioyl))biscarbamate
cercobin-m
spot kleen
thiophanate-methyl [iso]
SCHEMBL41622
dimethyl 4,4'-(o-phenylene)bis(3-thioallophanate)
dimethyl n,n'-[1,2-phenylenebis(azanediylcarbonothioyl)]dicarbamate
dimethyl n,n'-[1,2-phenylenebis(iminocarbonothioyl)]bis[carbamate]
dimethyl (1,2-phenylenedicarbamothioyl)biscarbamate
T3986
dimethyl 4,4-o-phenylene-bis (3-thiophanate)
W-110573
QGHREAKMXXNCOA-UHFFFAOYSA-N
allophanic acid, 4,4'-o-phenylenebis*3-thio-, dimethyl ester
allophanic acid, 4,4'-o-phenylenebis[3-thio-, dimethyl ester
methyl [2-(([(methoxycarbonyl)amino]carbothioyl)amino)anilino]carbothioylcarbamate #
labilite (salt/mix)
sigma
AB00052398_04
thiophanate-methyl, pestanal(r), analytical standard
mfcd00055294
AS-14875
Q126625
AMY22462
BRD-K90168339-001-04-5
E78643
CS-0012854
HY-B0842
SCHEMBL22261863
einecs 245-741-2
3336-f
1,2-bis(3-(ethoxycarbonyl)-2-thioureido)benzene
tiofanate etile [italian]
diethyl 4,4'-o-phenylenebis(3-thioallophanate)
1,2-di-(3-ethoxycarbonyl-2-thioureido)benzene
thiophanate-ethyl [french]
thiophanate [ban]
allophanic acid, 4,4'-o-phenylenebis(3-thio-, diethyl ester
cercobin wp 50%
caswell no. 344a
thiophanate [bsi:iso]
cleary's turf fungicide
brn 0939969
3336 turf fungicide
nf 35 (fungicide)
topsin e
vermadax
(1,2-phenylenebis(iminocarbonothioyl))biscarbamic acid diethyl ester
pelt (pesticide)
carbamic acid, (1,2-phenylenebis(iminocarbonothioyl))bis-, diethyl ester
thiophanat [german]
thiophanate-ethyl
1,2-bis(3-ethoxycarbonyl-2-thioureido) benzene
diethyl (1,2-phenylenebis(iminocarbonothioyl))bis(carbamate)
chipco spot kleen
epa pesticide chemical code 103401
cleary 3336
hsdb 6938
nsc 170810
nemafax
AKOS005449019
thiophanate ethyl
1,2-bis(ethoxycarbonylthioureido)benzene
allophanic acid,4'-o-phenylenebis[3-thio-, diethyl ester
nf 35, fungicide
4,4'-o-phenylenebis(ethyl 3-thioallophanate)
pelt
23564-06-9
enovit
thiophanate
1,2-bis[3-(ethoxycarbonyl)thioureido]benzene
bas 3220
nf 35
cercobin
topsin
thiophanat
cleary's 3336
thiophenite
1,2-bis(3-ethoxycarbonyl-2-thioureido)benzene
nsc-170810
diethyl 4,4'-o-phenylenebis[3-thioallophanate]
thiofanate
ethyl thiophanate
carbamic acid,2-phenylenebis(iminocarbonothioyl)]bis-, diethyl ester
nsc170810
diethyl 4,4'-o-phenylene-bis[3-thioallophanate]
topsin nf 35
NCGC00160551-01
STK377494
diethyl (benzene-1,2-diyldicarbamothioyl)biscarbamate
ethyl n-[[2-(ethoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate
C18918
dtxcid1014531
dtxsid3034531 ,
cas-23564-06-9
tox21_301909
NCGC00255347-01
chebi:82060 ,
CHEMBL2103777
5q0y96d5i8 ,
tiofanate etile
unii-5q0y96d5i8
FT-0630503
SCHEMBL20842
diethyl n,n'-(1,2-phenylenebis(iminocarbonothioyl))bis(carbamate)
thiophanate [mi]
thiophanate [hsdb]
diethyl 4,4'-(o-phenylene)bis(3-thioallophanate)
thiophanate [mart.]
thiophanate [iso]
diethyl (1,2-phenylenedicarbamothioyl)biscarbamate
diethyl n,n'-[1,2-phenylenebis(iminocarbonothioyl)]bis[carbamate]
diethyl n,n'-[1,2-phenylenebis(azanediylcarbonothioyl)]dicarbamate
thiophanat (german)
YFNCATAIYKQPOO-UHFFFAOYSA-N
diethyl 4,4'-o-phenylene-bis(3-thioallophanate)
allophanic acid, 4,4'-o-phenylenebis[3-thio-, diethyl ester
ethyl [2-(([(ethoxycarbonyl)amino]carbothioyl)amino)anilino]carbothioylcarbamate #
carbamic acid, [1,2-phenylenebis(iminocarbonothioyl)]bis-, diethyl ester
37359-51-6
ethyl [2-({[(ethoxycarbonyl)amino]carbothioyl}amino)anilino]carbothioylcarbamate
J-015148
thiphanate-ethyl
Q27155716
thiophanat-ethyl
diethyl 4,4 inverted exclamation mark -o-phenylenebis(3-thioallophanate) / topsin

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The aims of this study were to propose a bioindicator organism, the newt Triturus carnifex, for the assessment of toxicological impact of thiophanate methyl in the Campania region (Italy) and the possible adverse activity on the adrenal gland."( The newt Triturus carnifex as a model for monitoring the ecotoxic impact of the fungicide thiophanate methyl: adverse effects on the adrenal gland.
Capaldo, A; De Falco, M; Gay, F; Laforgia, V; Valiante, S; Varano, L; Virgilio, F, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
"After a single oral dosage of 40 mg thiophanate/kg in cattle, sheep and goats, the parent compound and its main metabolite: ethyl benzimidazol-1H-yl-2-carbamate (EBC) are evidenced in plasma by HPLC analysis for 60 to 72 hours."( [Pharmacokinetics and anti-Dicrocoelium activity of thiophanate and its major metabolite in ruminants].
Besse, S; Delatour, P; Romdane, MN, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
antifungal drugAny antifungal agent used to prevent or treat fungal infections in humans or animals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
thioureasCompounds of general formula RR'NC(=S)NR''R'''.
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
benzimidazole precursor fungicideCompounds based on 1,2-phenylenediamine in which one or both of the primary amino groups have been derivatised so as to permit subsequent benzimidazole formation, and which have been used as fungicides.
carbamate fungicideCompounds that contain a carbamate ester moiety as a key feature of their structure and which have been used as fungicides.
thioureasCompounds of general formula RR'NC(=S)NR''R'''.
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
benzimidazole precursor fungicideCompounds based on 1,2-phenylenediamine in which one or both of the primary amino groups have been derivatised so as to permit subsequent benzimidazole formation, and which have been used as fungicides.
carbamate fungicideCompounds that contain a carbamate ester moiety as a key feature of their structure and which have been used as fungicides.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (39)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.31620.003245.467312,589.2998AID2517
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency15.81140.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency20.69780.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency20.69780.025120.237639.8107AID886; AID893
interleukin 8Homo sapiens (human)Potency66.82420.047349.480674.9780AID651758
thioredoxin reductaseRattus norvegicus (Norway rat)Potency50.11870.100020.879379.4328AID588453
15-lipoxygenase, partialHomo sapiens (human)Potency12.58930.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency31.62280.141337.9142100.0000AID1490
TDP1 proteinHomo sapiens (human)Potency18.73410.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency43.27710.000714.592883.7951AID1259392
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency15.84890.707912.194339.8107AID720542
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency22.74070.011212.4002100.0000AID1030
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency7.69590.001022.650876.6163AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency20.42590.003041.611522,387.1992AID1159552; AID1159553; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency45.54850.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.94100.000229.305416,493.5996AID743069
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency39.81070.001019.414170.9645AID588536
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency1.73740.023723.228263.5986AID743222
aryl hydrocarbon receptorHomo sapiens (human)Potency62.43620.000723.06741,258.9301AID743085; AID743122
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency15.84890.001815.663839.8107AID894
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency65.72080.000323.4451159.6830AID743065; AID743067
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency21.19230.168316.404067.0158AID720504
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency40.50760.000627.21521,122.0200AID651741; AID720636; AID743202
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency12.58930.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency12.58930.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency12.58930.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency35.48130.00798.23321,122.0200AID2551
gemininHomo sapiens (human)Potency15.01930.004611.374133.4983AID624296; AID624297
lamin isoform A-delta10Homo sapiens (human)Potency35.48130.891312.067628.1838AID1487
Cellular tumor antigen p53Homo sapiens (human)Potency76.95880.002319.595674.0614AID651631
Nuclear receptor ROR-gammaHomo sapiens (human)Potency8.41270.026622.448266.8242AID651802
RAR-related orphan receptor gammaMus musculus (house mouse)Potency37.61620.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency1.74630.000221.22318,912.5098AID743054; AID743063
progesterone receptorHomo sapiens (human)Potency68.58960.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency54.94100.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency10.94360.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency19.06680.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency27.30600.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency40.30580.000229.305416,493.5996AID743079; AID743080; AID743091
aryl hydrocarbon receptorHomo sapiens (human)Potency27.30600.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency6.85900.001723.839378.1014AID743083
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency37.95340.154917.870243.6557AID1346877
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency54.48270.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency24.98450.037617.082361.1927AID1259364; AID1259388
Cellular tumor antigen p53Homo sapiens (human)Potency61.13060.002319.595674.0614AID651631; AID720552
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (134)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (38)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (71)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1112229Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as non-lesion areas compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1090148Fungicidal activity against Fusarium oxysporum assessed as mycelial inhibition at 28 +/- 2 degC measured after 7 days by food poison technique2005Journal of agricultural and food chemistry, Mar-23, Volume: 53, Issue:6
Organophosphorus derivatives containing piperazine dithiosemicarbazones as chemotherapeutants against fungal pathogens of sugarcane.
AID1112268Fungicidal activity against Neofusicoccum luteum G(s)-1 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112226Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as mean pathogen compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112257Fungicidal activity against Neofusicoccum luteum N(12)2 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1090149Fungicidal activity against Glomerella tucumanensis assessed as mycelial inhibition at 28 +/- 2 degC measured after 7 days by food poison technique2005Journal of agricultural and food chemistry, Mar-23, Volume: 53, Issue:6
Organophosphorus derivatives containing piperazine dithiosemicarbazones as chemotherapeutants against fungal pathogens of sugarcane.
AID1081526Fungicidal activity against Pseudomonas syringae pv. lachrymans in cucumber plant two seed leaves stage assessed as inhibition of mycelial growth at 500 ug/mL at 18 to 30 degC and above 80%RH relative to control2010Journal of agricultural and food chemistry, May-12, Volume: 58, Issue:9
Synthesis and biological activity of some novel trifluoromethyl-substituted 1,2,4-triazole and bis(1,2,4-triazole) Mannich bases containing piperazine rings.
AID1112271Fungicidal activity against Neofusicoccum australe Kat-1 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112254Fungicidal activity against Diplodia mutila Q assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112270Fungicidal activity against Neofusicoccum australe Mel-2 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1081525Fungicidal activity against Ascochyta citrallina in cucumber plant two seed leaves stage assessed as inhibition of mycelial growth at 500 ug/mL at 18 to 30 degC and above 80%RH relative to control2010Journal of agricultural and food chemistry, May-12, Volume: 58, Issue:9
Synthesis and biological activity of some novel trifluoromethyl-substituted 1,2,4-triazole and bis(1,2,4-triazole) Mannich bases containing piperazine rings.
AID632676Antifungal activity against Fusarium oxysporum assessed as growth inhibition at 500 ug/mL by potted plant test2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Molecular design, synthesis and bioactivity of glycosyl hydrazine and hydrazone derivatives: notable effects of the sugar moiety.
AID1104889Fungicidal activity against Fusarium graminearum F200Y harboring mutation at codon 200 of beta2 tubulin assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1080435Antifungal activity against Cochliobolus pallescens assessed as mycelial growth inhibition at 28 +/-2 degC after 7 days by food poison technique2008Journal of agricultural and food chemistry, Nov-26, Volume: 56, Issue:22
Organophosphorus derivatives containing isatin-3-hydrazones as chemotherapeutants against fungal pathogens of sugarcane.
AID1104886Fungicidal activity against Fusarium graminearum E198Q harboring mutation at codon 198 of beta2 tubulin assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1112244Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as dieback lesion length at 40 g AI /100 L applied 24 hr prior inoculation to pruning wound measured after 3 months2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1104891Fungicidal activity against Fusarium graminearum NT7 harboring mutation at codon 200 of beta2 tubulin assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1081390Fungicidal activity Thanatephorus cucumeris assessed as inhibition of mycelium growth at 50 mg/L at 24 degC measured after 2 days2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis and fungicidal activity of aryl carbamic acid-5-aryl-2-furanmethyl ester.
AID1112233Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at 40 g AI /100 L applied 24 hr prior inoculation to pruning wound measured after 3 months2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112261Fungicidal activity against Neofusicoccum australe Mel-2 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1104895Fungicidal activity against Fusarium graminearum 2021 assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1090147Fungicidal activity against Cochliobolus pallescens assessed as mycelial inhibition at 28 +/- 2 degC measured after 7 days by food poison technique2005Journal of agricultural and food chemistry, Mar-23, Volume: 53, Issue:6
Organophosphorus derivatives containing piperazine dithiosemicarbazones as chemotherapeutants against fungal pathogens of sugarcane.
AID1112231Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at dieback sites compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID426459Antifungal activity against Fusarium oxysporum at 500 ug/ml relative to control2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis, antifungal activities and 3D-QSAR study of N-(5-substituted-1,3,4-thiadiazol-2-yl)cyclopropanecarboxamides.
AID1080436Antifungal activity against Fusarium oxysporum assessed as mycelial growth inhibition at 28 +/-2 degC after 7 days by food poison technique2008Journal of agricultural and food chemistry, Nov-26, Volume: 56, Issue:22
Organophosphorus derivatives containing isatin-3-hydrazones as chemotherapeutants against fungal pathogens of sugarcane.
AID1104894Fungicidal activity against Fusarium graminearum Y50C harboring mutation at codon 50 of beta2 tubulin assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1104887Fungicidal activity against Fusarium graminearum ZJ80 harboring mutation at codon 198 of beta2 tubulin assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1081523Fungicidal activity against Sclerotinia sclerotiorum in cucumber plant two seed leaves stage assessed as inhibition of mycelial growth at 500 ug/mL at 18 to 30 degC and above 80%RH relative to control2010Journal of agricultural and food chemistry, May-12, Volume: 58, Issue:9
Synthesis and biological activity of some novel trifluoromethyl-substituted 1,2,4-triazole and bis(1,2,4-triazole) Mannich bases containing piperazine rings.
AID1112263Fungicidal activity against Diplodia mutila Q assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112255Fungicidal activity against Diplodia mutila F (12)2 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID376577Antifungal activity against Colletotrichum fragariae assessed as zone of inhibition2000Journal of natural products, Aug, Volume: 63, Issue:8
A new 2D-TLC bioautography method for the discovery of novel antifungal agents To control plant pathogens.
AID1104893Fungicidal activity against Fusarium graminearum 2052 harboring mutation at codon 167 of beta2 tubulin assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1080437Antifungal activity against Glomerella tucumanensis assessed as mycelial growth inhibition at 28 +/-2 degC after 7 days by food poison technique2008Journal of agricultural and food chemistry, Nov-26, Volume: 56, Issue:22
Organophosphorus derivatives containing isatin-3-hydrazones as chemotherapeutants against fungal pathogens of sugarcane.
AID1112260Fungicidal activity against Neofusicoccum australe J-3 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1104896Fungicidal activity against Fusarium graminearum DN83 harboring beta2 tubulin deletion mutation assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1112256Fungicidal activity against Diplodia mutila Iso-2 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112228Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at closest side shoot compound applied 24 hr prior inoculation to pruning wound measured after 6 months2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1104888Fungicidal activity against Fusarium graminearum E198K harboring mutation at codon 198 of beta2 tubulin assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1112269Fungicidal activity against Neofusicoccum australe J-3 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1104892Fungicidal activity against Fusarium graminearum F167Y harboring mutation at codon 167 of beta2 tubulin assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1112230Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at dieback edges compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1112266Fungicidal activity against Neofusicoccum luteum M (13)8 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID468443Inhibition of human FAAH at 1 uM2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
AID1112259Fungicidal activity against Neofusicoccum luteum G(s)-1 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1104890Fungicidal activity against Fusarium graminearum J2 harboring mutation at codon 198 of beta2 tubulin assessed as mycelial growth inhibition after 3 days2011Pest management science, Feb, Volume: 67, Issue:2
Localisation of the benzimidazole fungicide binding site of Gibberella zeae β2-tubulin studied by site-directed mutagenesis.
AID1112258Fungicidal activity against Neofusicoccum luteum M (13)8 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112265Fungicidal activity against Diplodia mutila F (12)2 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112227Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at area beyond node compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112262Fungicidal activity against Neofusicoccum australe Kat-1 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1081524Fungicidal activity against Pseudoperonospora cubensis in cucumber plant two seed leaves stage assessed as inhibition of mycelial growth at 500 ug/mL at 18 to 30 degC and above 80%RH relative to control2010Journal of agricultural and food chemistry, May-12, Volume: 58, Issue:9
Synthesis and biological activity of some novel trifluoromethyl-substituted 1,2,4-triazole and bis(1,2,4-triazole) Mannich bases containing piperazine rings.
AID1112264Fungicidal activity against Diplodia mutila Iso-2 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1081527Fungicidal activity against Corynespora cassiicola in cucumber plant two seed leaves stage assessed as inhibition of mycelial growth at 500 ug/mL at 18 to 30 degC and above 80%RH relative to control2010Journal of agricultural and food chemistry, May-12, Volume: 58, Issue:9
Synthesis and biological activity of some novel trifluoromethyl-substituted 1,2,4-triazole and bis(1,2,4-triazole) Mannich bases containing piperazine rings.
AID1112267Fungicidal activity against Neofusicoccum luteum N(12)2 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID519607Cytotoxicity against Hepatocyte cells assessed as cell viability by MTT assay2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
New active drugs against liver stages of Plasmodium predicted by molecular topology.
AID519608Selectivity index, ratio of TC50 for hepatocytes to IC50 for Plasmodium yoelii 2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
New active drugs against liver stages of Plasmodium predicted by molecular topology.
AID519606Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian hepatocytes after 48 hrs2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
New active drugs against liver stages of Plasmodium predicted by molecular topology.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (133)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (13.53)18.7374
1990's13 (9.77)18.2507
2000's27 (20.30)29.6817
2010's53 (39.85)24.3611
2020's22 (16.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials3 (2.38%)5.53%
Reviews1 (5.88%)6.00%
Reviews1 (0.79%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies1 (0.79%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
Other121 (96.03%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]